# InMed Pharmaceuticals Inc.: Form 8-K, filed Mar 30, 2026

- Company: [InMed Pharmaceuticals Inc.](/companies/inm.md) (CIK 1728328)
- Form: 8-K
- Filed: 2026-03-30
- Accepted by EDGAR: Mar 30, 2026, 17:37 ET
- Period: 2026-03-27
- Accession: 0001062993-26-001697
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1728328/000106299326001697/form8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1728328/000106299326001697/

## Items reported

- Item 3.01: Delisting notice
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1728328/000106299326001697/form8k.htm

Filed Mar 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001062993-26-001697. Last ingested by Listed: Nov 5, 2026, 12:16 ET. No prices; not investment advice.